The PD-L1 protein level in pancreatic cancer cell lines was downregulated after treatment with a concentration gradient and time gradient of the USP8 inhibitor and after Usp8 knockdown, according to western blotting analysis (Fig. 4a–c; Fig. S7b, c). This evidence concerns the gene USP8 and familial pancreatic carcinoma.